1. Home
  2. ITIC vs TOI Comparison

ITIC vs TOI Comparison

Compare ITIC & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investors Title Company

ITIC

Investors Title Company

N/A

Current Price

$277.13

Market Cap

517.8M

Sector

Finance

ML Signal

N/A

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$5.87

Market Cap

579.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITIC
TOI
Founded
1972
2007
Country
United States
United States
Employees
N/A
641
Industry
Specialty Insurers
Medical/Nursing Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
517.8M
579.9M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ITIC
TOI
Price
$277.13
$5.87
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.67
AVG Volume (30 Days)
56.3K
1.8M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
4.43%
N/A
EPS Growth
13.02
N/A
EPS
3.20
N/A
Revenue
$272,755,000.00
N/A
Revenue This Year
N/A
$30.15
Revenue Next Year
N/A
$25.77
P/E Ratio
$85.12
N/A
Revenue Growth
5.60
N/A
52 Week Low
$199.16
$2.32
52 Week High
$288.98
$6.11

Technical Indicators

Market Signals
Indicator
ITIC
TOI
Relative Strength Index (RSI) 65.89 64.43
Support Level $246.61 $3.28
Resistance Level $284.12 N/A
Average True Range (ATR) 7.91 0.37
MACD -0.26 0.02
Stochastic Oscillator 78.37 78.10

Price Performance

Historical Comparison
ITIC
TOI

About ITIC Investors Title Company

Investors Title Co operates in the title insurance and exchange services sectors. The Company has two reportable segments. The Company's primary business activity, and one of its reportable operating segments, is the issuance of residential and commercial title insurance through ITIC and NITIC. The company's second reportable operating segment is providing tax-deferred real property exchange services through its subsidiaries, Investors Title Exchange Corporation (ITEC) and Investors Title Accommodation Corporation (ITAC).

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

Share on Social Networks: